Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

NCT01341405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: CG100649
DRUG: Celecoxib

Sponsor

CrystalGenomics, Inc.